Related scientific articles (all)

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Authors : Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C
Year : 2013
Journal : Ann Oncol
Volume : 24(3)
Pages : 647-54

Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs. (epub online 2012)

Authors : Merckaert I, Libert Y, Lieutenant F, Moucheux A, Farvacques C, Slachmuylder JL, Razavi D
Year : 2013
Journal : Psychooncology
Volume : 22(6)
Pages : 1389-95

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.

Authors : Metzger-Filho O, Procter M, de Azambuja E, Leyland-Jones B, Gelber Rd, Dowsett M, Loi S, Saini KS, Cameron D, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Bell R, Sotiriou C, Viale G, Piccart-Gebhart M
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(16)
Pages : 1954-60

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.

Authors : Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M
Year : 2013
Journal : Oncologist
Volume : 18(2)
Pages : 134-40

A Randomized Study of Interferon a-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

Authors : Bosly A, Grigg A, Holte H, Gisselbrecht C, Radford J, Rossi A, Lopez-Guillermo A, Trneny M, Sebban C, Hagberg H, Leal da Costa F, Colombat P, Bron D, Coiffier B
Year : 2013
Journal : Oncologist
Volume : 18(11)
Pages : 1189

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.

Authors : Partridge AH, Gelber S, Piccart-Gebhart M, Focant F, Scullion M, Holmes E, Winer EP, Gelber Rd
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(21)
Pages : 2692-8

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Authors : Kerklaan BM, Diéras V, Le Tourneau C, Mergui-Roelvink M, Huitema AD, Rosing H, Beijnen JH, Marreaud S, Govaerts AS, Piccart-Gebhart M, Schellens JH, Awada A
Year : 2013
Journal : Cancer Chemother Pharmacol
Volume : 71(1)
Pages : 53-62

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?

Authors : Pistilli B, Bellettini G, Giovannetti E, Codacci-Pisanelli G, Azim HA, Benedetti G, Sarno MA, Peccatori FA
Year : 2013
Journal : Cancer Treat Rev
Volume : 39(3)
Pages : 207-11

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Authors : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Year : 2013
Journal : PLoS One
Volume : 8(3)
Pages : e59756

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98.

Authors : Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, de Azambuja E, Quinaux E, Di Leo A, Michiels S, Piccart-Gebhart M, Sotiriou C
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(7)
Pages : 860-7

Rational approach of leucocytosis in adults].

Authors : Bron D
Year : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pages : 339-42

Stratified medicine: a call for action.

Authors : Jacob I, Awada A, Payne K, Annemans L
Year : 2013
Journal : Expert Rev Pharmacoecon Outcomes Res
Volume : 13(3)
Pages : 277-9

Euthanasia: from ethical debate to clinical reality.

Authors : Berghmans T, Lossignol D
Year : 2012
Journal : Eur. Respir. J.
Volume : 40(4)
Pages : 804-5

Communication skills training for residents : which variables predict learning of skills?

Authors : Bragard I, Merckaert I, Libert Y, Delvaux N, Etienne AM, Marchal S, Reynaert C, Razavi D
Year : 2012
Journal : Open Journal of Medical Psychology
Volume : 1
Pages : 68-75

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Authors : Ignatiadis M, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1653-5

Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Authors : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Year : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pages : 157-68

Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer.

Authors : Berghmans T, Remmelink M, Awada A
Year : 2012
Journal : Lung Cancer : Targets and Therapy
Volume : 3
Pages : 91-99

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Authors : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Year : 2012
Journal : Breast
Volume : 21(1)
Pages : 20-6

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Authors : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Year : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pages : 21-7

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Authors : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Year : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pages : 14-21